Guindam, Jhunrick A.

HRN: 16-26-11  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/23/2026
CEFUROXIME 750MG (VIAL)
03/23/2026
03/30/2026
IV
675mg
Q8
PCAP-C WITH HRAD
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: